Sentinel Lymph Node Examination in Breast Carcinoma in Situ
Authors:
Ja. Mergancová; Ji. Mergancová; I. Hrnčířová 1; Z. Kerekes 2; M. Hácová 3
Authors place of work:
Chirurgická klinika, Pardubická krajská nemocnice a. s., přednosta: doc. MUDr. Jiří Šiller, Ph. D.
; Mamodiagnostické centrum Pardubice s r. o.
1; Patologie Litomyšl
2; Patologicko-anatomické oddělení, Pardubická krajská nemocnice a. s., primář: MUDr. Pavel Rothröckel
3
Published in the journal:
Rozhl. Chir., 2011, roč. 90, č. 7, s. 393-396.
Category:
Monothematic special - Original
Summary
Introduction:
Breast carcinoma in situ is defined as non-invasive form of carcinoma. However, we can see infiltration of sentinel lymph node even in this disease. The aim of this work was to determine indication criteria for detection of sentinel lymph node in breast carcinoma in situ.
Materials and methods:
Summary of current knowledge about examination of sentinel lymph node in breast carcinoma in situ. Comparison of the results with our own results.
Results:
We summarized the results of 10 trials studying ductal carcinoma in situ (DCIS) and 4 studies with DCIS with microinvasion. Sentinel lymph node infiltration is described in 0 to 7.3%, or 9.3 to 29.4%. In our department during the period of one year, we diagnosed 7 carcinomas in situ, in the final histology examination 5 DCIS, 1 DCIS with microinvasion and 1 lobular carcinoma in situ (LCIS) with microinvasion. Sentinel lymph node infiltration was diagnosed only in LCIS with microinvasion. The other, non-sentinel axillary lymph nodes, were negative in this patient. The indication criteria for sentinel lymph node examination in breast carcinoma in situ in our department include: greater extent of microcalcifications, indication for total mastectomy for diffuse involvement, microcalcifications with palpable resistance, preoperative diagnosis of carcinoma in situ from core-cut biopsy, carcinoma in situ G3 confirmed in open extirpation.
Conclusions:
The sentinel lymph node examination in breast carcinoma in situ can change staging of the disease, as well as the treatment modality. In case that the sentinel lymph node is positive, the disease is undoubtedly invasive and the invasive part of the tissue was not seen in the biopsy sample.
Key words:
in situ breast cancer – sentinel node – microcalcification
Zdroje
1. Stuart, K., Boyages, J., Brennan, M., et al. Ductal carcinoma in situ – management update. Aus. Fam. Physician, 2005; 34: 949–954.
2. Schwartz, G. F., Solin, L., Olivotto, I., et al. Consensus conference on the treatment classification of ductal carcinoma in situ of the breast, April 22-25, 1999. Cancer, 2000; 68: 946–954.
3. Leonard, G., Swain, S. Ductal carcinoma in situ, complexities and challenges. J. Natl. Cancer Inst., 2004; 96: 906–920.
4. Hughes, L. L., Wang, M., Page, D. L. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of Eastern Cooperative Oncology Group. J. Clin. Oncol., 2009; 27: 5319–5324.
5. Vincens, E., Alves, K., Lauratet, B., et al. Margin status in ductal carcinoma in situ of the breast. Bull Cancer, 2008; 95: 1155–1159.
6. Mokbel, K., Cutuli, B. Heterogeneity the ductal carcinoma in situ and its effects of managements. Lancet Oncol., 2006; 7: 756–765.
7. Morrow, M. Breast conservation and negative margins: how much is enough? Breast, 2009; 18(Suppl 3): S84–S86.
8. Dunne, C., Burke, J. P., Morrow, M., et al. Effect of the margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J. Clin. Oncol., 2009; 27: 1615–1620.
9. Mansell, R. E. Ductal carcinoma in situ: surgery and radiotherapy. Breast, 2003; 12: 447–450.
10. Goldhirsch, A., Ingle, J. N., Gerlber, R. D., et al. Thresholds for the therapies: highlights of the Saint Gallen International Experts Consensus, on the primary therapy of early breast cancer. Ann. Oncol., 2009; 20(8): 1319–1329.
11. Farante, G., Zurrida, S., Galimberti, V., et al. The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Instituto Europeo di Oncologia (IEO), Milan, Italy. Breast cancer Res. Treat., 2010 Aug.
12. Edge, S. B., Sheldon, D. G. Counterpoint: sentinel lymph node biopsy is not indicated for ductal carcinoma in situ. J. Natl. Compr. Canc. Netw., 2003; 1: 207–212.
13. Pendas, S., Dauway, E., Guiliano, R., et al. Sentinel node biopsy in ductal carcinoma in situ patients. Ann. Surg. Oncol., 2007; 7: 15–20.
14. Ansari, B., Ogston, S. A., Purdie, C. A., et al. Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast. Br. J. Surg., 2008; 95: 547–554.
15. Wilkie, C., White, L., Dupont, E., et al. An update of sentinel lymp node mapping in patients with ductal carcinoma in situ. Am. J. Surg., 2005; 190: 563–566.
16. Murphy, C. D., Jones, J. L., Hughes, J. S., et al. Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion? Am. J. Surg., 2008; 196: 566–568.
17. Moore, K., Sweeney, K., Wilson, M., et al. Outcomes for women with DCIS and positive sentinel node: a multi-institutional audit. Ann. Surg. Oncol., 2005; 14: 2911–2917.
18. Kelly, T. A., Kim, J. A., Patrick, R., et al. Axillary lymph node metastases in patient with final diagnosis of ductal carcinoma in situ. Am. J. Surg., 2003; 186: 368–370.
19. Zavagno, G., Belardinelli, V., Marconato, R., et al. Sentinel lymph node metastasis from mammary ductal carcinoma in situ with microinvasion. The Breast, 2007; 16: 146–151.
20. Veronesi, P., Intra, M., Vento, A. R., et al. Sentinel lymph node biopsy for localised ductal carcinoma in situ? The Breast, 2005; 14: 520–522.
21. Camp, R., Feezor, R., Kasraeian, A., et al. Sentinel lymph node biopsy for ductal carcinoma in situ: an evolving approach at the University of Florida. Breast J, 2005; 11: 394–397.
22. Zavagno, G., Carcoforo, P., Marconato, R., et al. Role of axillary sentinel lymph node biopsy in patient with pure ductal carcinoma in situ of the breast. BMC Cancer, 2005; 5: 28–34.
23. Katz, A., Gage, I., Evans, S., et al. Sentinel lymph node positivity of patients with ductal carcinoma in situ or microinvasive breast cancer. Am. J. Surg., 2006; 191: 761–766.
24. Wilkie, C., White, L., Dupont, E., et al. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. Am. J. Surg., 2005; 190: 563–566.
25. Farkas, E. A., Stolier, A. J., Teng, S. C., et al. An argument against routine sentinel node mapping for DCIS. Am. Surg., 2004; 70: 13–18.
26. Török, K., Péley, G., Mátrai, Z., et al. The role of sentinel lymph node biopsy for staging patients with ductal carcinoma in situ of the breast. Magy Seb, 2006; 59: 173–178.
27. Tada, K., Ogiya, A., Kimura, K., et al. Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancer. World J. Surg. Oncol., 2010 Jan; 8: 6.
28. Intra, M., Zurrida, S., Maffini., F., et al. Sentinel lymph node metastasis in microinvasive breast cancer. Ann. Surg. Oncol., 2003; 10: 1160–1165.
29. Cserni, G., Ambrózay, É., Serényi, P., et al. A nem operatív patológiai emlödiagnosztika eredményei. Magy. Radiol., 2005; 79: 178–183.
30. Zujewski, J., Eng-Wong, J. Sentinel lymph node biopsy in the management of ductal carcinoma in situ. Clin. Breast Cancer, 2005; 6: 216–222.
31. Dupont, E. L., McCann, C., Cox, C. E. Ductal carcinoma in situ of the breast. Cancer Control., 1999; 6(3): 264–271.
32. Silverstein, M. J. Ductal carcinoma in situ of the breast. Annu Rev. Med., 2000; 51: 17–32.
Štítky
Surgery Orthopaedics Trauma surgeryČlánok vyšiel v časopise
Perspectives in Surgery
2011 Číslo 7
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole vs. Tramadol in Postoperative Analgesia
- Spasmolytic Effect of Metamizole
Najčítanejšie v tomto čísle
- Antibiotic Prophylaxis in Acute Surgical Procedures – The Current Praxis in Czech Republic
- Arthritis Sternoclavicularis as a Cause of Mediastinitis
- Surgical Management of Perforations during Colonoscopy
- 750 Satisfied Patients? Stapled Haemorrhoidopexy (Longo Procedure) for the Treatment of Haemorrhoids and Anal Canal Prolapse: A Review of our 10-year Experience